Dextrose (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Dextrose drug offered from Baxter Healthcare Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | dextrose monohydrate |
SUBSTANCE NAME: | DEXTROSE MONOHYDRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
START MARKETING DATE: | 2017-10-19 |
END MARKETING DATE: | 0000-00-00 |
Dextrose HUMAN PRESCRIPTION DRUG Details:
Item Description | Dextrose from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(g/50mL) |
START MARKETING DATE: | 2017-10-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0338-9521_940b1b3e-8c77-470a-9169-208a114387a7 |
PRODUCT NDC: | 0338-9521 |
APPLICATION NUMBER: | |
Other DEXTROSE MONOHYDRATE Pharmaceutical Manufacturers / Labelers: